Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 127
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second dose cohort in the dose escalation phase of its Phase 1/1b clinical trial...
Gavins Felicity
-
April 18, 2024
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks Investor Excitement”
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial Hypertension
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection Treatments
iBio Inc. (NYSE: IBIO) Signs Licensing Agreement for RTX-003 with RubrYc...
Gavins Felicity
-
September 6, 2021
0
Theravance Biopharma Inc. (NASDAQ: TBPH) Announce Phase 2b Izencitinib Dose-Finding Study...
Ward Sport
-
September 6, 2021
0
Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine...
Gavins Felicity
-
September 6, 2021
0
Ascendis Pharma A/S (NASDAQ: ASND) Receives FDA Approval For SKYTROFA...
Matt Wade
-
September 3, 2021
0
Sorrento Therapeutics Inc. (NASDAQ; SRNE) Enters agreement for IP rights in...
Kate Hudson
-
September 3, 2021
0
1
...
126
127
128
...
325
Page 127 of 325
Recent Post
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
Gavins Felicity
-
April 18, 2024
0
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
April 1, 2024
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...
March 29, 2024
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
March 26, 2024
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024